αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib

αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib

Case presentation Here we report a case of refractory EOC in a patient who had relapsed after multiline chemotherapy. The patient received autologous T cells that contained sequences encoding single-chain variable fragments specific for MSLN and full-length antibody for PD-1 (αPD-1). The modified T...

Full description

Bibliographic Details
Main Authors: Hui Wang, Zhong Li, Yan Sun, Wei Mao, Min Yuan, Juemin Fang, Qing Xu, Na Ding, Xinling Guo, Zhiwei Zhang, Bailu Xie, Zhicai Lin, Fei Qin, Wenqi Chu, Huanlong Qin, Qijun Qian
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/2/e001162.full

Internet

https://jitc.bmj.com/content/9/2/e001162.full

Similar Items